OBJECTIVE: Adult epiglottitis is a potentially life-threatening infection and its reported incidence has not decreased since widespread H. influenzae Type B vaccination. Our study aims to review the presentation, management and outcome of epiglottitis in 169 adults admitted to Liverpool Hospital, Sydney, Australia, between January 1999 to January 2009. METHOD: Retrospective case note review was conducted on all admissions with epiglottitis in patients aged 18 and above as identified from the hospital admissions database. All patients were reviewed by an ENT registrar or consultant and the diagnosis was confirmed by fiberoptic nasolaryngoscopy or direct laryngoscopy under general anesthetic. The main out-come measure was the need for intubation or tracheotomy. Univariate analysis was performed to determine factors that led to a worse outcome. RESULTS: There were 80 males and 89 females in the cohort, with a median age of 51 years (range 18 to 74). The common symptoms and signs at presentation were odynophagia and dysphagia (94%), dysphonia (65%), and stridor (33%). Endotracheal intubation was performed in 16 (10%) patients and an awake tracheotomy was required in 4 (2%) patients. Blood cultures were performed in 97 (57%) patients but positive findings were present in only 12 (7%). Seven cultures were positive for H. influenzae, 3 for S. pneumoniae and 2 for S. aureus. Cefriaxone and flucoxacillin was the most common antibiotic combination used. Dexamethasone was used in 103 patients (61%). 35 patients (20%) had diabetes mellitus as a comorbidity and 3 were immunocompromised. There was no mortality and the average length of stay in hospital was 5 days (range 3-9). 140 patients (82%) were admitted to ICU for an mean duration of 2 days(range 1-5). On univariate analysis, the presence of diabetes was found to be predictive of the need for intubation or tracheotomy (pϽ0.05). CONCLUSION: Adult epiglottitis needs to be suspected in patients with no direct visible cause of odynophagia. Fiberoptic laryngoscopy is the gold standard for diagnosis and close airway monitoring is crucial. Conservative management of the airway is a viable option but the presence of diabetes makes airway intervention more likely. The use of steroids aids in symptom alleviation and hastening resolution of airway swelling with no negative sequelae.
Alpha-1-Blockers for Obstructive Salivary Gland Diseases
Philippe Katz, MD (presenter) OBJECTIVE: Alpha-blockers are widely used in urology as an aid in treating stenosis and lithiasis. A similar pathophysiology is encountered in the salivary gland, and alpha-1 adrenoreceptors have been shown to exist in salivary ducts. The aim of our study was to evaluate the safety and effectiveness of alpha-blockers in treating obstructive salivary gland diseases. METHOD: Retrospective study over 3 years of patients with ductal stenosis, allergic pseudo-parotitis or sialolithiasis after lithotripsy in the parotid or submandibular glands. Male patients were given 2.5 mg bid of the alpha-blocker alfuzosin and female patients 2.5 mg bid. At 3 months, ultrasound was performed and a subjective evaluation of symptoms was obtained via a questionnaire. RESULTS: 352 patients were treated for 3 to 24 months (average 8 months). Twelve patients (3.4%) reported adverse effects (orthostatic hypotension, cutaneous allergy, dysejaculation, dysuria) and 10 (2.8%) stopped the treatment after 3 months. A large subjective improvement in symptoms was reported by 80% of the 69 patients with stenosis, 79% of the 89 with allergic pseudo-parotitis, and 67% of the 112 with resid-ual parotid lithiasis. 42% of the 82 patients treated for residual submandibular lithiasis reported a large improvement, significantly lower than for the other diseases (p Ͻ 0.05). No malefemale difference was noted for safety or efficacy. Ultrasound showed in all cases a decrease in intraglandular ductal distension. CONCLUSION: Alfuzosin was well-tolerated and improved symptoms related to stenosis or lithiasis of the parotid and submandibular glands in a majority of patients. A randomized controlled study is warranted to confirm the efficacy of this approach as compared to conventional treatments.
Angioedema of the Larynx
Teruhisa Suzuki, MD (presenter); Koichi Omori, MD OBJECTIVE: To clarify the clinical manifestations of laryngeal edema in patients with angioedema. METHOD: Retrospective study in a university hospital. Patients with angioedema who visited the otolaryngology clinic in our institution were examined (including the face, lips, tongue, pharynx, larynx, and neck) for the presence of oral cavities and upper airway edema. In addition, the etiology of the angioedema in each patient was surveyed. RESULTS: Nineteen patients (11 men, 8 women; mean age, 63 years) were diagnosed with angioedema, of which 26 received treatment (one patient visited our clinic three times, five patients visited us twice each). The edema was observed in the pharynx in 21 (81%), the tongue in 19 (73%), the arytenoids in 14 (54%), the lip in 10 (39%) and the epiglottis in 7 patients (27%). Edema of the larynx, including the arytenoids and/or epiglottis, was present in 15 of the 26 patients (58%) receiving treatment. The etiology of the angioedema was identified in 10 patients as follows: hereditary angioedema-2, renin-angiotensin system inhibitors-4, estrogen-1, and diet-3. One patient underwent tracheal intubation and another underwent tracheotomy for airway management. CONCLUSION: Patients with angioedema who initially consult an otolaryngology clinic have a more than 50% chance of laryngeal edema; therefore examination of the upper airway is recommended for all patients diagnosed with angioedema.
Anthropometric Data as a Predictor of OSA Severity
Thiago Sonego, MD (presenter); Jose Pinto, MD; Luciana Godoy, MD; Carolina Leal, MD; Marina Artico, MD OBJECTIVE: 1) Correlate the neck (NC), abdominal (AC), and pelvic (PC) circumference to the apnea/hypopnea index (AHI) and the saturation of oxy-hemoglobin of patients with Obstructive Sleep Apnea (OSA). 2) Investigate the relationship between the values and the severity of the disease. METHOD: A prospective descriptive study with 82 patients evaluated for complaints suggestive of OSA, assessed by a group of ENTs from July 2008 to December 2009. All patients underwent polysomnography, measures of body mass index-(BMI), NC, AC, and PC. Analysis of the mean, standard deviations and Spearman correlation analysis were conducted. RESULTS: The average age for women was 44 years, and for men, 43. Mean AHI among men was 39 events/hr and 21 events/hr among women. The anthropometric measurements of NC rating was 34.5 cm in women and 41.3 cm in men. AC was 94.3 cm in women and 101.5 cm in men, and PC was 105.7 cm in men and 108.7 cm in women. In men, NC was the most correlated to AHI (r ϭ ϩ0.389 p ϭ 0.001) and when we join the groups, the same relationship holds (r ϭ ϩ0.411 p Ͻ0.001). The relationship between AC had a higher correlation to AHI than BMI in men (AC r ϭ ϩ0.358 p ϭ 0.003 BMI r ϭ ϩ0.321 p ϭ 0.009). In the female group, there was significant relationship only in comparison of NC, AC and BMI to the mean saturation of oxy-hemoglobin, keeping the NC more sensitive. (r ϭ -0.621 p ϭ 0.01). CONCLUSION: Obesity is correlated to the severity of the OSA. Measured NC is a better predictor than AC and BMI of sleep-related respiratory disorders severity.
